Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A13306 | 30038584 | Front Physiol | Stanniocalcin 2 Ameliorates Hepatosteatosis Through Activation of STAT3 Signaling. | 2018 | Details |
| A13307 | 30038487 | Drug Des Devel Ther | Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis. | 2018 | Details |
| A13308 | 30038464 | World J Gastroenterol | Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model". | 2018 | Details |
| A13309 | 30037166 | Gut Liver | Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study. | 2019 | Details |
| A13310 | 30037134 | Int J Mol Sci | High-Content Screening of a Taiwanese Indigenous Plant Extract Library Identifies Syzygium simile leaf Extract as an Inhibitor of Fatty Acid Uptake. | 2018 | Details |
| A13311 | 30037123 | Nutrients | Dietary Fibre as a Unifying Remedy for the Whole Spectrum of Obesity-Associated Cardiovascular Risk. | 2018 | Details |
| A13312 | 30037080 | Nutrients | Understanding the Impact of Dietary Cholesterol on Chronic Metabolic Diseases through Studies in Rodent Models. | 2018 | Details |
| A13313 | 30036883 | Cell Physiol Biochem | Regulatory Role of Endothelial PHD2 in the Hepatic Steatosis. | 2018 | Details |
| A13314 | 30036865 | Cell Physiol Biochem | Cangju Qinggan Jiangzhi Decoction Reduces the Development of NonAlcoholic Steatohepatitis and Activation of Kupffer Cells. | 2018 | Details |
| A13315 | 30036479 | Mol Pharm | Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier. | 2018 | Details |
| A13316 | 30036051 | J Agric Food Chem | Cichoric Acid Prevents Free-Fatty-Acid-Induced Lipid Metabolism Disorders via Regulating Bmal1 in HepG2 Cells. | 2018 | Details |
| A13317 | 30034912 | Liver Res | FOXO transcription factors in non-alcoholic fatty liver disease. | 2017 | Details |
| A13318 | 30034633 | Oncotarget | Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis. | 2018 | Details |
| A13319 | 30033779 | Expert Rev Gastroenterol Hepatol | Health benefits of Mediterranean diet in nonalcoholic fatty liver disease. | 2018 | Details |
| A13321 | 30032630 | Rev Esp Enferm Dig | Role of the PNPLA3 polymorphism rs738409 on silymarin + vitamin E response in subjects with non-alcoholic fatty liver disease. | 2018 | Details |
| A13322 | 30032465 | Sleep Breath | Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians. | 2018 | Details |
| A13323 | 30032383 | Abdom Radiol (NY) | Reference range of liver corrected T1 values in a population at low risk for fatty liver disease-a UK Biobank sub-study, with an appendix of interesting cases. | 2019 | Details |
| A13324 | 30031769 | Gastroenterology | Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis. | 2018 | Details |
| A13325 | 30030460 | Sci Rep | Uncaria tomentosa improves insulin sensitivity and inflammation in experimental NAFLD. | 2018 | Details |
| A13326 | 30030064 | Life Sci | Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients. | 2018 | Details |
| A13327 | 30029691 | Cardiovasc Diabetol | Beneficial effects of cherry consumption as a dietary intervention for metabolic, hepatic and vascular complications in type 2 diabetic rats. | 2018 | Details |
| A13328 | 30028245 | J Am Coll Nutr | Effect of Soy Milk on Metabolic Status of Patients with Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial. | 2018 | Details |
| A13329 | 30028193 | Br J Radiol | Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis. | 2018 | Details |
| A13330 | 30027532 | Hepatol Int | Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cells. | 2018 | Details |
| A13331 | 30027139 | Hepatol Commun | Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts. | 2018 | Details |
| A13332 | 30027137 | Hepatol Commun | Management of nonalcoholic fatty liver disease: Lessons learned from type 2 diabetes. | 2018 | Details |
| A13333 | 30026784 | Nutr Metab (Lond) | Changes in lysophospholipids and liver status after weight loss: the RESMENA study. | 2018 | Details |
| A13334 | 30026731 | Front Endocrinol (Lausanne) | Comparative Study of Different Diets-Induced NAFLD Models of Zebrafish. | 2018 | Details |
| A13335 | 30026676 | Food Nutr Res | Bitter melon extract ameliorates palmitate-induced apoptosis via inhibition of endoplasmic reticulum stress in HepG2 cells and high-fat/high-fructose-diet-induced fatty liver. | 2018 | Details |
| A13336 | 30026586 | Sci Rep | Substitution of linoleic acid with α-linolenic acid or long chain n-3 polyunsaturated fatty acid prevents Western diet induced nonalcoholic steatohepatitis. | 2018 | Details |
| A13337 | 30026388 | Cold Spring Harb Mol Case Stud | Exome sequencing of an adolescent with nonalcoholic fatty liver disease identifies a clinically actionable case of Wilson disease. | 2018 | Details |
| A13339 | 30025558 | Biomed Environ Sci | Association between IgG N-glycans and Nonalcoholic Fatty Liver Disease in Han Chinese. | 2018 | Details |
| A13340 | 30025200 | Liver Int | Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study. | 2018 | Details |
| A13341 | 30025198 | Liver Int | Regression of hepatocellular adenoma after bariatric surgery in severe obese patients. | 2018 | Details |
| A13342 | 30024933 | PLoS One | miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling. | 2018 | Details |
| A13343 | 30023358 | Front Med (Lausanne) | Calcium Signaling in Liver Injury and Regeneration. | 2018 | Details |
| A13344 | 30023333 | Adv Pharm Bull | Effects of Pharmacologic Dose of Resveratrol Supplementation on Oxidative/Antioxidative Status Biomarkers in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Trial. | 2018 | Details |
| A13345 | 30021122 | Pharmacol Res | Future trends in the treatment of non-alcoholic steatohepatitis. | 2018 | Details |
| A13346 | 30019598 | Antioxid Redox Signal | Does Nox2 Overactivate in Children with Nonalcoholic Fatty Liver Disease? | 2018 | Details |
| A13347 | 30019340 | Hepatology | Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study. | 2018 | Details |
| A13348 | 30019185 | J Physiol Biochem | Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation. | 2018 | Details |
| A13349 | 30019089 | Eur J Nutr | Association between dietary total antioxidant capacity and hepatocellular ballooning in nonalcoholic steatohepatitis: a cross-sectional study. | 2018 | Details |
| A13350 | 30018721 | Am J Transl Res | Activation of the CXCL16/CXCR6 pathway promotes lipid deposition in fatty livers of apolipoprotein E knockout mice and HepG2 cells. | 2018 | Details |
| A13351 | 30018458 | Eur J Clin Nutr | Reappraisal of attenuated insulin sensitivity in the evolution of non-alcoholic fatty liver disease. | 2018 | Details |
| A13352 | 30018094 | BMJ Open | Short-term postoperative outcomes of colorectal cancer among patients with chronic liver disease: a national population-based study. | 2018 | Details |
| A13353 | 30017991 | Free Radic Biol Med | The role of iron in hepatic inflammation and hepatocellular carcinoma. | 2018 | Details |
| A13355 | 30017357 | Cell Metab | Mitochondrial Stasis Reveals p62-Mediated Ubiquitination in Parkin-Independent Mitophagy and Mitigates Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13356 | 30016988 | Lipids Health Dis | Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress. | 2018 | Details |
| A13357 | 30016799 | Dig Dis | The Pattern of Elevated Liver Function Tests in Nonalcoholic Fatty Liver Disease Predicts Fibrosis Stage and Metabolic-Associated Comorbidities. | 2018 | Details |
| A13358 | 30016770 | Dig Dis | Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A13359 | 30016459 | J Neuropathol Exp Neurol | Histological Features of Cerebellar Neuropathology in Patients With Alcoholic and Nonalcoholic Steatohepatitis. | 2018 | Details |
| A13360 | 30016121 | Autoimmunity | The association of non-alcoholic fatty liver disease with thyroid peroxidase and thyroglobulin antibody: A new insight from SPECT-China study. | 2018 | Details |
| A13361 | 30015906 | Mol Med Rep | Establishment of a novel non‑alcoholic fatty liver disease model using cholesterol‑fed rabbits with reference to the potential role of endoplasmic reticulum stress. | 2018 | Details |
| A13362 | 30015905 | Mol Med Rep | Analysis of non‑alcoholic fatty liver disease microRNA expression spectra in rat liver tissues. | 2018 | Details |
| A13363 | 30015859 | Int J Mol Med | Effect of celastrol on toll‑like receptor 4‑mediated inflammatory response in free fatty acid‑induced HepG2 cells. | 2018 | Details |
| A13364 | 30015675 | Curr Opin Lipidol | Non-parenchymal hepatic cell lipotoxicity and the coordinated progression of non-alcoholic fatty liver disease and atherosclerosis. | 2018 | Details |
| A13365 | 30014517 | Hepatology | ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis. | 2019 | Details |
| A13366 | 30014489 | Hepatology | Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States. | 2019 | Details |
| A13367 | 30014320 | Hormones (Athens) | Sarcopenic obesity. | 2018 | Details |
| A13368 | 30014284 | Biol Trace Elem Res | Evaluation of Plasma Trace Elements in Different Stages of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13369 | 30013758 | Middle East J Dig Dis | The Association between Angiotensin II Type 1 Receptor Gene A1166C Polymorphism and Non-alcoholic Fatty Liver Disease and Its Severity. | 2018 | Details |
| A13370 | 30013757 | Middle East J Dig Dis | Correlation between Serum Ferritin Level and Histopathological Disease Severity in Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A13371 | 30013416 | Clin Med Insights Gastroenterol | An Evidence-Based Review of Statin Use in Patients With Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13372 | 30013137 | Nat Commun | Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis. | 2018 | Details |
| A13373 | 30012432 | Clin Gastroenterol Hepatol | Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13374 | 30012333 | Gastroenterology | Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases. | 2018 | Details |
| A13375 | 30012085 | BMC Cardiovasc Disord | Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old. | 2018 | Details |
| A13376 | 30011790 | Int J Mol Sci | New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis. | 2018 | Details |
| A13377 | 31595238 | Porto Biomed J | NAFLD and cardiovascular disease. | 2018 | Details |
| A13378 | 30009816 | Gastroenterology | Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016. | 2018 | Details |
| A13379 | 30009772 | Exp Mol Pathol | Different roles of FAT10, FOXO1, and ADRA2A in hepatocellular carcinoma tumorigenesis in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH). | 2018 | Details |
| A13380 | 30009716 | Endocr Metab Immune Disord Drug Targets | Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation. | 2019 | Details |
| A13381 | 30009570 | Physiol Rep | Curcumin supplementation mitigates NASH development and progression in female Wistar rats. | 2018 | Details |
| A13382 | 30009361 | Folia Morphol (Warsz) | The differential effects of high-fat and high- -fructose diets on the liver of male albino rat and the proposed underlying mechanisms. | 2018 | Details |
| A13383 | 30008738 | PPAR Res | Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice. | 2018 | Details |
| A13384 | 30006580 | Int J Obes (Lond) | Zinc alpha2 glycoprotein protects against obesity-induced hepatic steatosis. | 2018 | Details |
| A13385 | 30006517 | Sci Rep | Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers. | 2018 | Details |
| A13386 | 30006193 | Biochem Pharmacol | Pharmacological intervention of liver triacylglycerol lipolysis: The good, the bad and the ugly. | 2018 | Details |
| A13387 | 30006154 | Biochim Biophys Acta Mol Basis Dis | GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice. | 2018 | Details |
| A13388 | 30006135 | Arch Biochem Biophys | Ablation of carotenoid cleavage enzymes (BCO1 and BCO2) induced hepatic steatosis by altering the farnesoid X receptor/miR-34a/sirtuin 1 pathway. | 2018 | Details |
| A13389 | 30005700 | Clin Epigenetics | Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways. | 2018 | Details |
| A13390 | 30005625 | BMC Gastroenterol | Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults. | 2018 | Details |
| A13391 | 30002817 | F1000Res | Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts. | 2018 | Details |
| A13392 | 30002695 | Arch Med Sci | Angiopoietin-like protein 2 and angiopoietin-like protein 6 levels in patients with nonalcoholic fatty liver disease. | 2016 | Details |
| A13393 | 30002342 | Nutrients | Celiac Disease and Liver Disorders: From Putative Pathogenesis to Clinical Implications. | 2018 | Details |
| A13396 | 30001365 | PLoS One | Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India. | 2018 | Details |
| A13397 | 29998870 | Indian J Med Res | Erythrocyte membrane fatty acid profile & serum cytokine levels in patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A13399 | 29998462 | Aliment Pharmacol Ther | Hepatic steatosis is highly prevalent across the paediatric age spectrum, including in pre-school age children. | 2018 | Details |
| A13400 | 29996339 | Zhonghua Gan Zang Bing Za Zhi | [Effect of lipid-induced macrophage M1/M2 polarization on lipid metabolism in hepatocytes]. | 2018 | Details |
| A13401 | 29996338 | Zhonghua Gan Zang Bing Za Zhi | [Correlation between serum uric acid and risk of new-onset nonalcoholic fatty liver disease: a 5-year observational cohort study]. | 2018 | Details |
| A13402 | 29994981 | Transplantation | Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation. | 2019 | Details |
| A13403 | 29993072 | Food Funct | Involvement of autophagy in the beneficial effects of resveratrol in hepatic steatosis treatment. A comparison with energy restriction. | 2018 | Details |
| A13404 | 29992975 | Sci Rep | A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD. | 2018 | Details |
| A13405 | 29992886 | Curr Vasc Pharmacol | Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives. | 2019 | Details |
| A13406 | 29992631 | J Eur Acad Dermatol Venereol | Position statement for the management of comorbidities in psoriasis. | 2018 | Details |
| A13407 | 29992593 | Clin Endocrinol (Oxf) | Liver biochemical abnormalities in Turner syndrome: A comprehensive characterization of an adult population. | 2018 | Details |
| A13408 | 29992215 | Lab Chip | Microphysiological flux balance platform unravels the dynamics of drug induced steatosis. | 2018 | Details |
| A13409 | 29992039 | Pilot Feasibility Stud | A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease. | 2018 | Details |
| A13410 | 29991976 | Oxid Med Cell Longev | Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13411 | 29991872 | World J Gastroenterol | Apoptosis and non-alcoholic fatty liver diseases. | 2018 | Details |